Hi [[ session.user.profile.firstName ]]

Reimagining Healthcare: The Case for Collaborative Innovation

Healthcare and life sciences companies are no strangers to the power of collaborations. However, connecting different R&D labs and creating a strong ecosystem for data sharing was not widespread, carefully managed, nor generally backed by long-term partnerships.

Learn how healthcare and life sciences organizations in Hong Kong and around the world are driving collaborative innovation
Examine the role of private and public sector partnerships, and why multi-cloud interconnections and data sharing are becoming increasingly important
Explore how new infrastructure concepts like edge computing are shaping the future of the healthcare industry
Recorded Mar 3 2021 90 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Rajaneesh R. Kurup, Head of Healthcare Strategy, Equinix Asia-Pacific Sanjit Kumar, IT Director, AstraZeneca
Presentation preview: Reimagining Healthcare: The Case for Collaborative Innovation

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
Equinix Hong Kong Limited - Channel
Equinix, Inc. (Nasdaq: EQIX) connects the world's leading businesses to their customers, employees and partners inside the most-interconnected data centers across over 50 metros worldwide.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Reimagining Healthcare: The Case for Collaborative Innovation
  • Live at: Mar 3 2021 4:00 am
  • Presented by: Rajaneesh R. Kurup, Head of Healthcare Strategy, Equinix Asia-Pacific Sanjit Kumar, IT Director, AstraZeneca
  • From:
Your email has been sent.
or close